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ABSTRACT 
Blood analysis is time consuming and laboratories may require methods of storing 
samples until time permits analysis. The effects of storage on the sample are mostly 
unknown, yet some laboratories commonly store blood samples to allow processing of 
samples in batches. Cryopreservation is proposed as a convenient means of 
preserving blood samples, as the associated cold temperatures render cryopreservation 
an ideal storage method for tests requiring viable cells. In the literature, few studies 
have explored whether cryopreserved whole blood samples can be utilised effectively 
for cytogenetic testing. 
This study extended the work on cryopreservation of blood to observe the cytogenetic 
effects of storing whole blood samples for an extended period. In this study three 
cytogenetic tests: Sister Chromatid Exchange (SCE), Micronucleus Assay (MN) and 
Fluorescence in situ Hybridisation (FISH) were conducted on whole blood samples 
from ten participants to observe whether the results from the cytogenetic tests are 
statistically consistent over a prolonged period of cryopreservation (fresh, one month, 
three months and six months). These tests were conducted on a single blood sample 
cryopreserved from each participant. 
The results indicated that cryopreservation of whole blood is not a reliable method for 
storing blood samples prior to cytomolecular tests. The culturing of lymphocytes 
from cryopreserved blood was found to be inconsistent and the lymphocyte viability 
after cryopreservation reduced. When lymphocytes were successfully cultured, SCE 
and MN demonstrated increased genetic damage after a period of cryopreservation 
(P= <0.050 and P= 0.016 respectively) but FISH was not successfully performed on 
cryopreserved blood samples. It is unclear from the results obtained whether 
cryopreservation actually induces genetic damage or if the observed damage was the 
result of the specific storage technique. 
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